HCV Drugs

Medical Advocates
Pegylated Interferon Alfa-2a (Pegasys)

Hepatic Disease Data

New and Noteworthy
HBV Indications
HCV Indications
HIV/HCV Indications

Drug Index HCV Drugs Main New/Newsworthy Home Page

Last Update: July 17, 2006
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

July 2005

Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals.
Kappelhoff BS, Huitema AD, Yalvac Z, Clin Pharmacokinet. 2005;44(8):849-61.

HBV Indications

Efficacy

Journal Papers, Abstracts, and Commentaries

Peginterferon-alpha2a for the treatment of hepatitis B infection.
Cooksley WG.
Expert Opin Pharmacother. 2005 Jul;6(8):1373-80.
Abstract

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-
positive chronic hepatitis B.
Cooksley WG, Piratvisuth T, Lee SD, et al.
J Viral Hepat. 2003 Jul;10(4):298-305.
Abstract

HCV Drugs Main New/Newsworthy Home Page

Pegylated Interferon Alfa-2a Hepatic Disease Main Page